MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111 | -71.8% | 87,113 | -27.0% | 0.00% | – |
Q2 2023 | $394 | -21.2% | 119,345 | -1.7% | 0.00% | – |
Q1 2023 | $500 | -29.3% | 121,377 | +0.7% | 0.00% | – |
Q4 2022 | $707 | -99.9% | 120,519 | +7.6% | 0.00% | – |
Q3 2022 | $758,000 | +17.3% | 112,039 | -19.9% | 0.00% | – |
Q2 2022 | $646,000 | +17.2% | 139,819 | +1.3% | 0.00% | – |
Q1 2022 | $551,000 | -22.6% | 138,034 | +20.6% | 0.00% | – |
Q4 2021 | $712,000 | -92.3% | 114,447 | -88.3% | 0.00% | -100.0% |
Q3 2021 | $9,250,000 | -70.6% | 980,896 | -57.7% | 0.00% | -66.7% |
Q2 2021 | $31,475,000 | -34.6% | 2,317,747 | -22.1% | 0.00% | -40.0% |
Q1 2021 | $48,121,000 | -45.3% | 2,974,087 | -10.0% | 0.01% | -44.4% |
Q4 2020 | $87,929,000 | +158.2% | 3,304,346 | +80.7% | 0.01% | +125.0% |
Q3 2020 | $34,049,000 | +95.3% | 1,828,619 | +145.4% | 0.00% | +100.0% |
Q2 2020 | $17,438,000 | – | 745,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |